Instalab
logoInstalab

Proteus Mirabilis

Stool Test
Check whether your gut is carrying the organism behind struvite kidney stones and catheter-related urinary infections.
4.9 (3,829 reviews)
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Easy self-collection kit
Get results
Explained with clear next steps, no medical jargon

Should you take a Proteus Mirabilis test?

This test is most useful if any of these apply to you.

Getting UTIs Over and Over
If infections keep coming back, this checks whether the organism sits in your gut reservoir, one of several places repeat bladder infections start.
Told You Have Struvite Stones
These stones form around infection, not diet. This test checks for the bacterium that raises urine pH and makes them grow.
Living With Crohn's or Colitis
This organism is enriched in active inflammatory bowel disease. Tracking it adds one more line to your picture of gut ecology.
Facing a Urologic Procedure
Knowing this organism is in your gut before a catheter or operation is worth flagging to your team, who can culture to check resistance.

About Proteus Mirabilis

If you get urinary tract infections over and over, the organism causing them usually is not arriving from outside. It is living in your own intestine, and it travels the short distance from the bowel to the bladder again and again. Proteus mirabilis is one of the bacteria that does this.

This stool test looks for the organism's DNA and tells you whether it is present in your gut and roughly how much is there. What it cannot tell you is whether you are sick. Most people who carry it have no symptoms at all.

A Normal Resident That Sometimes Turns

Proteus mirabilis is a normal resident of the human intestine. In healthy people it stays at very low levels, a tiny fraction of the bacterial DNA in a stool sample. At that level it is background. Finding it is not a diagnosis.

What makes it worth measuring is where it goes next. The gut is the reservoir: the place the organism lives quietly before it seeds an infection somewhere else. In practice, that somewhere else is almost always the urinary tract.

So the number on this report is a colonization marker, not an infection marker. It answers "is this organism available to cause trouble," not "is it causing trouble now." The difference matters for how you should use the result, and the rest of this page is mostly about that distinction.

Urinary Tract Infections and Kidney Stones

This is the association with the strongest evidence behind it. Proteus mirabilis is an established uropathogen, and its real prominence is in complicated urinary infection. It is one of the leading causes of catheter-associated urinary infection, especially in people catheterized long term, and it turns up often in infections involving stones, structural abnormalities, or older age. Ordinary uncomplicated cystitis is a different story: E. coli causes the large majority of those episodes, and this organism accounts for a much smaller share.

The mechanism is specific to this organism. Proteus mirabilis makes urease. That enzyme splits urea and drives urine pH upward, and alkaline urine makes minerals crystallize. This is why the bacterium is the classic cause of struvite stones. Those are the large branching kidney stones that grow around infection rather than around dietary excess. It also builds biofilm on urinary catheters, blocking them and shielding itself from antibiotics.

If you have had recurrent urinary infections and nobody has explained why they keep coming back, knowing whether this organism is in your gut reservoir is useful context. It falls well short of proof. Establishing that your gut carriage is the source of your bladder infections would mean matching the strain in your urine to the strain in your stool, which this test does not do. But recurrent infection plus gut carriage plus alkaline urine or a history of struvite stones is a coherent picture, and it is worth pursuing further rather than writing the episodes off as bad luck.

Crohn's Disease and Ulcerative Colitis

Proteus mirabilis shows up repeatedly in inflammatory bowel disease research. In Crohn's disease it is enriched in both stool and the lining of the colon, and in one cohort it was detected roughly three times as often in patients as in healthy controls, 18.5% versus 5.6%. A large metagenomic analysis found it among six species of gut gram-negative bacteria enriched during active Crohn's disease and ulcerative colitis.

The limitation here is a big one. Nearly all of this work is cross-sectional: researchers looked at sick people and healthy people at one moment and compared them. That design cannot tell you whether the bacterium helped cause the inflammation or simply bloomed because an inflamed gut is a friendlier place for it to grow. Both stories fit the data equally well.

In acute diarrheal illness the organism is isolated more often than in healthy controls. Again, association, not cause. Surveillance work finds it in a small share of childhood diarrhea cases, usually alongside other pathogens that are the more likely culprits.

The Resistance Question

The part of this organism's story that changes real decisions is drug resistance. Proteus mirabilis often carries extended-spectrum beta-lactamase genes. Those enzymes disable many common antibiotics, including most cephalosporins. In one Ghanaian study of stool isolates from diarrhea patients, 57% of Proteus mirabilis strains produced them. Series from other countries report figures in a broadly similar range, so the exact percentage depends heavily on where the strains were collected.

Resistant strains behave differently in the gut. In a long-term care cohort followed with serial rectal cultures for a median of 211 days, multidrug-resistant Proteus mirabilis cleared in only 1 of 15 colonization episodes, compared with about half of episodes for other resistant gram-negative organisms. Those were nursing home residents, frail and heavily exposed to antibiotics, so the numbers do not transfer cleanly to a healthy person with a positive stool test. What they do say about the organism itself is that once it establishes in a resistant form, it tends to stay.

That persistence has consequences. In 817 hospitalized patients followed for a year, carrying any multidrug-resistant gram-negative organism raised the risk of a later infection with one roughly fivefold and roughly doubled the risk of dying from any cause, and both associations held after adjusting for other patient factors. Within that cohort, prior resistant Proteus mirabilis was among the organisms with the highest risk of a later infection, though the estimate came from small numbers and should be read as a direction rather than a precise figure. Carriage there was established by clinical cultures in hospitalized patients, not by a quantitative stool PCR in someone who feels well, which is a real gap between that evidence and this test.

If you are heading into a urologic procedure, a catheter, or surgery, it is useful to know this organism is in your gut. What this test cannot tell you is whether your strain is resistant. It detects the species, not its antibiotic susceptibility. Resistance comes from a culture, where the lab grows the organism and tests drugs against it. A positive stool result is a reason to raise the question with your surgical team, not an answer to it.

Why the Absence of a Reference Range Is Not a Technicality

There are no validated clinical cutoffs for Proteus mirabilis in stool. No professional body has defined a level above which you should act. Population studies that tried to establish normal gut ranges found enormous person-to-person variation and stopped short of clinical thresholds.

Where the organism is used diagnostically, it is never alone. Research models that separate inflammatory bowel disease from health rely on panels of many bacterial species together, usually alongside fecal calprotectin. Proteus mirabilis contributes; it does not decide.

No study has yet shown that acting on a quantitative stool level of this organism changes an outcome. Treat it as a research-grade marker you are tracking early. That is not a reason to skip it. It is a reason to read it as one line in a larger picture rather than as a verdict.

Why a Single Reading Can Fool You

Low-abundance organisms are the least stable things in a stool test. Daily quantitative profiling of healthy adults found swings of up to a hundredfold in many bacterial genera over six weeks. Rare organisms fluctuate the most. A single Proteus mirabilis reading carries real sampling noise.

Recent antibiotics are the biggest distorter. Antibiotic exposure measurably lowers how reproducible a stool result is, particularly within a month of a course. Macrolide antibiotics in particular push Proteobacteria, the broad bacterial group this organism belongs to, upward, and those effects appear to linger longer than with penicillins. Recovery is partial: most of the gut community rebounds within weeks of a course, but some changes can persist for months.

Two other things to know. PCR detects DNA, including DNA from organisms that are no longer alive, so a positive result does not prove viable bacteria are present. And this is a species-specific test: a normal result here says nothing about Salmonella, Shigella, Campylobacter, or the other pathogens a standard enteric panel looks for.

Tracking Your Trend

Because there is no threshold to cross, your own trajectory is the useful signal. One reading tells you the organism is present or absent right now. A series tells you whether it is establishing itself, receding, or holding steady, and that is what you actually want to know.

Get a baseline. If you are changing something that could plausibly matter, such as finishing a course of antibiotics or having a catheter removed, retest in three to six months. After that, annually is a reasonable cadence if you have a reason to watch this, such as recurrent urinary infections, a catheter, or inflammatory bowel disease. Space any retest at least a month past an antibiotic course, or you will be measuring the drug rather than your gut.

One caution about interpreting change. No human study has shown that a specific diet, probiotic, or prebiotic raises or lowers Proteus mirabilis in stool. Pooled trial data suggest probiotics can modestly reduce gut carriage of some resistant bacteria in general, but nothing specific to this species has been demonstrated. If your number falls after a probiotic, do not assume the probiotic did it. Normal variability in a rare organism can produce that shift on its own.

What to Do With an Unexpected Result

Start by pairing this result with your symptoms, because the two together determine everything. A positive result with no urinary or gut symptoms is colonization, and colonization alone is not treated. Antibiotics given for a positive stool PCR in a person who feels fine disturb the microbiome and push resistance forward without any benefit in return.

The combinations that warrant follow-up are specific. Positive result plus recurrent urinary infections: culture your urine during the next episode, so you can see whether the organism in your bladder matches the one in your gut, and check urine pH. If struvite stones are a possibility, that is worth imaging. Positive result plus diarrhea, blood, or weight loss: fecal calprotectin is the better next test. It measures inflammation in the bowel wall and separates true inflammatory disease from a functional gut problem far better than any single bacterial count can. If it comes back high, a gastroenterology referral is the right next step.

If you have a urologic procedure or catheter ahead, mention a positive result to the team beforehand, and raise whether a culture with susceptibility testing is worth doing first. That is the moment this information can change a clinical decision rather than just describe your gut.

Frequently Asked Questions

References

21 studies
  1. L. K. Muhsal, Lisa Theis, J. Overmann, a. HamprechtClinical Microbiology Reviews2025
  2. Wen-pin Tseng, Yee-chun Chen, Shang-yu Chen, Shey-ying Chen, Shan-chwen ChangAntimicrobial Resistance and Infection Control2018
  3. Babak Khorsand, Hamid Asadzadeh Aghdaei, E. Nazemalhosseini-mojarad, Hamidreza HouriFrontiers in Cellular and Infection Microbiology2022
  4. Jingwan Zhang, Qin Liu, J. Teh, a. Hamilton, a. Wilson-o'brien, J. Ching, Ke-Li Yang, Zhilu Xu, S. Wong, J. Sung, M. Kamm, M. Morrison, Jun Yu, S. NgGastroenterology2020